Plus Therapeutics, Inc. (PSTV) Financials

$1.09

north_east $0.01 (0.93%)
Day's range
$1.04
Day's range
$1.09

PSTV Income statement / Annual

Last year (2023), Plus Therapeutics, Inc.'s total revenue was $4.91 M, an increase of 2,093.30% from the previous year. In 2023, Plus Therapeutics, Inc.'s net income was -$13.32 M. See Plus Therapeutics, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Operating Revenue $4.91 M $224,000.00 $0.00 $303,000.00 $7.00 M $2.98 M $6.41 M $11.38 M $11.66 M $7.60 M
Cost of Revenue $9.69 M $712,000.00 $66,000.00 $2.70 M $5.37 M $1.15 M $1.32 M $2.72 M $3.19 M $2.94 M
Gross Profit -$4.78 M -$488,000.00 -$66,000.00 -$2.40 M $1.63 M $1.84 M $5.09 M $8.67 M $8.47 M $4.66 M
Gross Profit Ratio -0.97 -2.18 0 -7.91 0.23 0.62 0.79 0.76 0.73 0.61
Research and Development Expenses $9.69 M $9.70 M $5.57 M $3.48 M $5.37 M $5.52 M $13.36 M $16.20 M $19.00 M $15.11 M
General & Administrative Expenses $8.54 M $10.24 M $6.85 M $6.41 M $4.82 M $5.58 M $7.59 M $8.56 M $9.77 M $15.95 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $468,000.00 $643,000.00 $3.59 M $3.61 M $2.66 M $6.41 M
Selling, General & Administrative Expenses $8.54 M $10.24 M $6.85 M $6.41 M $5.29 M $6.22 M $11.19 M $12.17 M $12.43 M $22.36 M
Other Expenses -$9.69 M $1,000.00 $6,000.00 $781,000.00 -$1.23 M -$470,000.00 $13,000.00 $233,000.00 $169,000.00 -$608,000.00
Operating Expenses $8.54 M $19.94 M $12.43 M $9.89 M $10.66 M $11.75 M $25.78 M $28.37 M $31.43 M $37.46 M
Cost And Expenses $18.23 M $19.94 M $12.43 M $9.89 M $10.66 M $11.75 M $27.09 M $31.09 M $34.61 M $40.40 M
Interest Income $400,000.00 $147,000.00 $19,000.00 $50,000.00 $55,000.00 $43,000.00 $33,000.00 $19,000.00 $9,000.00 $6,000.00
Interest Expense $395,000.00 $711,000.00 $932,000.00 $1.11 M $1.86 M $1.92 M $2.05 M $2.59 M $3.38 M $4.37 M
Depreciation & Amortization $628,000.00 $712,000.00 $419,000.00 $369,000.00 $441,000.00 $379,000.00 $2.15 M $1.18 M $1.09 M $779,000.00
EBITDA -$12.69 M -$18.85 M -$12.49 M -$6.77 M -$987,000.00 -$6.58 M -$18.49 M -$18.27 M -$14.27 M -$32.22 M
EBITDA Ratio -2.58 -84.58 0 -30.26 -0.39 -2.25 -2.88 -1.61 -1.86 -4.29
Operating Income Ratio -2.71 -88 0 -31.63 -0.52 -2.94 -3.23 -1.73 -1.31 -4.27
Total Other Income/Expenses Net $5,000.00 -$563,000.00 -$907,000.00 $1.34 M $374,000.00 -$116,000.00 -$2.00 M -$2.34 M -$3.46 M -$4.93 M
Income Before Tax -$13.32 M -$20.28 M -$13.40 M -$8.24 M -$3.28 M -$8.88 M -$22.69 M -$22.05 M -$18.74 M -$37.37 M
Income Before Tax Ratio -2.71 -90.51 0 -27.2 -0.47 -2.98 -3.54 -1.94 -1.61 -4.92
Income Tax Expense $0.00 $563,000.00 $932,000.00 $1.11 M $9.46 M $1.99 M $2.06 M $2.83 M $3.55 M $3.76 M
Net Income -$13.32 M -$20.84 M -$14.33 M -$9.35 M -$12.74 M -$12.63 M -$22.69 M -$22.05 M -$18.74 M -$37.37 M
Net Income Ratio -2.71 -93.03 0 -30.85 -1.82 -4.24 -3.54 -1.94 -1.61 -4.92
EPS -4.24 -11.91 -17.78 -31.67 -138.1 -1090.08 -5253.82 -9564.43 -14983.21 -40310.68
EPS Diluted -4.24 -11.91 -17.78 -31.67 -138.1 -1090.08 -5253.82 -9564.43 -14983.21 -40310.68
Weighted Average Shares Out $3.14 M $1.75 M $805,945.00 $295,189.00 $92,267.00 $11,590.00 $4,318.00 $2,305.00 $1,251.00 $927.00
Weighted Average Shares Out Diluted $3.14 M $1.75 M $805,945.00 $295,189.00 $92,267.00 $11,590.00 $4,318.00 $2,305.00 $1,251.00 $927.00
Link